Not registered yet? Get a free account.
Sign UpYou're about to leave our website and go to an external link. Are you sure?
Samarth Life Sciences Private Limited, is an unlisted private company incorporated on 20 February, 2014. It is classified as a private limited company and is located in , Maharashtra. It's authorized share capital is INR 26.23 lac and the total paid-up capital is INR 25.52 lac.
Samarth Life Sciences's operating revenue range is Over INR 500 cr for the financial year ending on 31 March, 2024. It's EBITDA has increased by 27.34% over the previous year. At the same time, it's book networth has increased by 38.92%.
Read more
** All rupee values in INR crores.
* GST not included
** Reports & MCA filings will be based on the latest available financials.
** Delivery timelines are on best-effort basis during working hours. Filings 3-4 hours. Reports 24-48 hours.
* INR 349 for 20+ credits purchase
1 credit = one company dashboard
| State | Type | Address |
|---|
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Rajiv Gunvantlal Shah
Shareholder
|
02080936 | 12 years |
| Whole-time Director | Krishna Murthy Narasimhaprasad | 02057653 | 4 years |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
Financials upto March 2024 available in Tofler Pro
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
As per information available, the company has no registered charges.
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SAMARTH JIULONG PHARMACEUTICALS PRIVATE LIMITED |
Strike Off
|
1.0 L | 2 | Maharashtra |
| SAMARTH BIOLOGICALS LLP |
Active
|
10.0 L | 1 | Karnataka |
| ZALAWAD BUSINESS FORUM |
Active
|
0.0 | 1 | Maharashtra |
| MONEY HONEY CONSULTANTS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Maharashtra |
| SAMARTH PHARMA PRIVATE LIMITED |
Active
|
25.0 L | 1 | Maharashtra |
| MONEY HONEY FINANCIAL SERVICES PRIVATE LIMITED |
Active
|
1.2 Cr | 1 | |
| PENANG ENTERPRISES PRIVATE LIMITED |
Active
|
20.6 L | 1 | Maharashtra |
| CELLCYS LABS PRIVATE LIMITED |
Active
|
1.7 Cr | 1 | Maharashtra |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Cellcys Biotech Sdn. Bhd. (Malaysia) | Malaysia | - | - |
Read more
The incorporation date of SAMARTH LIFE SCIENCES PRIVATE LIMITED is 20 February, 2014
The authorized share capital of SAMARTH LIFE SCIENCES PRIVATE LIMITED is INR ₹ 26.2 L.
The paid-up capital of SAMARTH LIFE SCIENCES PRIVATE LIMITED is INR ₹ 25.5 L.
The registered address of SAMARTH LIFE SCIENCES PRIVATE LIMITED is Gala No136 New Ashirwad Industrial Estate,1st Flr Building No.5, Ram Mandir Road, Goregaon, West, Mumbai City, Mumbai, Maharashtra, India, 400062 - 400062
The CIN number of SAMARTH LIFE SCIENCES PRIVATE LIMITED is U24233MH2014PTC253426.